Inizio wins two PM360 Innovation Awards for AI and t...

Innovations helping pharma teams make smarter commercialization decisions

Inizio has received two PM360 2026 Innovation Awards recognizing our advancements in AI, data, and technology that are helping pharmaceutical organizations make smarter, faster commercialization decisions.

The awards recognize STEM AI and Predictev™ - strengthening our position as the global leaders in Intelligent Commercialization™.

PM360's Innovation Awards celebrate the people, ideas, technologies, and strategies pushing the health and life sciences industry ahead and redefining what's possible.

STEM AI: Transforming HCP interactions into actionable field force intelligence

Receiving the Innovative Artificial Intelligence Award, STEM AI is an AI-powered call recording, analysis, and coaching solution designed for pharmaceutical field teams.

It transforms healthcare professional (HCP) interactions into personalized coaching, actionable insights, benchmarking analytics, and leadership reporting. Since launch, STEM AI has generated significant market interest, with 40 pilot opportunities across 27 pharmaceutical companies worldwide.

Read the full STEM AI feature here.

Predictev™: Moving pharma commercialization from reactive analysis to predictive decision-making

Receiving the Innovative Data and Cybersecurity Award, Predictev™ is our intelligent decision engine that enables life sciences organizations to anticipate HCP and patient behavior, rather than simply analyze past performance.

Since launch, Predictev™ has onboarded eight pharmaceutical clients and 750 active users, generating more than 16,500 predictive scenarios. Early adopters have reported measurable commercial gains, including improved market share, accelerated patient starts, and millions of dollars in incremental revenue and cost savings, demonstrating its ability to transform commercialization from reactive decision-making to proactive planning.

Read the full Predictev™ feature here.

Driving Intelligent Commercialization™ through expert insight, data, and AI

These awards reflect a broader shift in pharma commercialization - from fragmented data and retrospective analysis toward unified intelligence that helps teams anticipate change, act faster, and make more confident decisions.

"These awards are fantastic recognition of how our teams are already using AI to create real value for our clients. We're not just talking about the potential of AI; we're putting it to work today, and our deep expertise, proprietary data, and decades of knowledge are helping us move faster and make it more powerful. We don't see AI replacing the expertise at the heart of commercialization but amplifying it. STEM AI and Predictev™ are great examples of that combination in action; helping our clients make smarter decisions, act faster, and ultimately drive better outcomes." - Mary-Kate McGarry, Chief Strategy & Innovation Officer, Inizio

At Inizio, Intelligent Commercialization™ brings together expert insight, data, technology, and AI to help pharmaceutical organizations translate insight into action across the entire commercialization lifecycle.

Read PM360's full 2026 Innovation Issue here.